eMagin (NYSE:EMA – Get Free Report) had its target price lowered by research analysts at Barclays from $55.00 to $53.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s price target indicates a potential upside of 4.38% from the stock’s current price.
Other equities analysts have also issued reports about the stock. Wall Street Zen upgraded shares of eMagin from a “strong sell” rating to a “sell” rating in a report on Saturday, April 18th. Weiss Ratings downgraded shares of eMagin from a “buy (b)” rating to a “buy (b-)” rating in a research report on Thursday, July 2nd. One analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $60.50.
View Our Latest Analysis on EMA
eMagin Stock Performance
Institutional Trading of eMagin
A number of large investors have recently bought and sold shares of the business. Parallel Advisors LLC grew its position in eMagin by 130.9% during the 1st quarter. Parallel Advisors LLC now owns 508 shares of the company’s stock worth $26,000 after purchasing an additional 288 shares during the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of eMagin by 1,375.0% in the fourth quarter. EverSource Wealth Advisors LLC now owns 708 shares of the company’s stock valued at $35,000 after buying an additional 660 shares during the last quarter. DGS Capital Management LLC acquired a new stake in shares of eMagin during the first quarter worth about $349,000. Venturi Wealth Management LLC purchased a new position in shares of eMagin during the fourth quarter worth about $356,000. Finally, Versant Capital Management Inc grew its holdings in shares of eMagin by 15.0% during the second quarter. Versant Capital Management Inc now owns 7,396 shares of the company’s stock worth $392,000 after buying an additional 963 shares during the last quarter.
eMagin Company Profile
eMagin Corporation engages in the design, develop, manufacture, and market of organic light-emitting diode (OLED) miniature displays on-silicon micro displays, virtual imaging products that utilize OLED micro displays, and related products in the United States and internationally. It offers super video graphics array (SVGA) + OLED micro displays; digital SVGA OLED-XL; super extended graphics array OLED-XL/XLS; video graphics array OLED-XL; and widescreen ultra-extended graphics array OLED-XL. The company also provides design reference kits, which include a micro display and associated electronics to help original equipment manufacturers (OEMs) to evaluate micro display products; near-eye virtual imaging modules that incorporate its OLED-on-silicon micro displays with its lenses and electronic interfaces for integration into OEM products; prism optics, a molded plastic prism lens that permits its AMOLED micro displays to provide realistic images that can be viewed for extended periods with reduced eye-fatigue; and driver boards.
Recommended Stories
- Five stocks we like better than eMagin
- AI Data Centers Are Splitting Winners From Pretenders in Infrastructure Stocks
- 3 of the Market’s Most-Upgraded Tech Stocks Right Now
- Albemarle’s Blowout Quarter Shows Why Lithium Still Matters
- Can DICK’S Turn Foot Locker Into a Winner?
Receive News & Ratings for eMagin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin and related companies with MarketBeat.com's FREE daily email newsletter.
